Copyright
©The Author(s) 2022.
World J Gastroenterol. Jan 7, 2022; 28(1): 76-95
Published online Jan 7, 2022. doi: 10.3748/wjg.v28.i1.76
Published online Jan 7, 2022. doi: 10.3748/wjg.v28.i1.76
Virus | Public health priorities | Research priorities |
Hepatitis A | Increased vaccination of high-risk individuals; Improved sanitation and vaccination in camps for displaced persons | Medical treatments for those with acute liver failure |
Hepatitis B | Increase uptake of vaccination; Identifying undiagnosed individuals; Linkage to care | Establishing treatment end-points; Identifying curative treatment |
Hepatitis C | Microelimination; Reducing re-infection rates; Identifying undiagnosed individuals; Harm reduction | Vaccination; Confirming most effective HCC surveillance strategies |
Hepatitis D | Identification of infected individuals; Clarifying current disease burden of HDV | Novel therapies |
Hepatitis E | Increased screening of blood products/change in donor policies; Educating immunosuppressed patients of risk of food-borne transmission; Further understanding of sources of infection | RCT to confirm optimal dose and duration of ribavirin therapy; Novel treatments; Vaccination; Greater understanding of genetic mutations |
- Citation: Dunn R, Wetten A, McPherson S, Donnelly MC. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World J Gastroenterol 2022; 28(1): 76-95
- URL: https://www.wjgnet.com/1007-9327/full/v28/i1/76.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i1.76